Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1198)
  3. Review (75)
  4. Research Letter (49)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2971)
  2. Department of Medicine (2971)
  3. Hematologic Malignancies, Division of (2848)
  4. Survivorship Research (1389)
  5. GSK Faculty (931)
  6. CTCR Scholars (874)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Sean Devlin (470)
  4. Ann Jakubowski (459)
  5. Gunjan Shah (447)
  6. Heather Landau (436)

More People

Years
  1. 2025 (68)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (95)

More Publications

Publishers
  1. American Society of Hematology (989)
  2. Elsevier Inc. (767)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2971)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Advances in ex vivo T cell depletion – Where do we stand?
    Review

    Bryant, A. R.; Perales, M. A.
    Advances in Cell and Gene Therapy (2019)

    Fulltext@MSK | Save
  • Highly favorable outcomes with salvage radiation therapy followed by autologous transplant in relapsed and refractory DLBCL patients with minimal or no response to salvage chemotherapy
    Meeting Abstract

    Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Blood (2019)

    Fulltext@MSK | Save
  • Graft versus host disease leads to elimination of tissue-resident innate lymphoid cells following experimental and clinical allogeneic transplantation
    Meeting Abstract

    Vinci, P.; Garcia-Martinez, E.; O'Connor, M. H.; Egorova, A.; Kuttiyara, J.; Arnhold, V.; Ponce, D. M.; Hanash, A. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients
    Meeting Abstract

    Thompson, J. C.; Ren, Y.; Romero, K. M.; Lew, M. V.; Bush, A. T.; Messina, J. A.; Jung, S. H.; Miller, J. M.; Zenko, Z.; Jenq, R. R.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Development of HHV-6-specific immunity after cord blood transplantation in adults depends on reconstitution of thymopoiesis and regeneration of CD4(+) T cells
    Meeting Abstract

    Tijaro-Ovalle, N. M.; Li, S.; Defilipp, Z.; Politikos, I.; Joyce, R. M.; Armand, P.; Ho, V. T.; Koreth, J.; Nikiforow, S.; Alyea, E. P. 3rd; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Retrospective analysis of gemcitabine and oxaliplatin (GemOx)-based treatment in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Schade, J. R.; Kim, C.; Drill, E.; Qiu, A.; Batlevi, C. L.; Caron, P.; Colbourn, D. S.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Allogeneic stem cell transplantation (alloHSCT) for chronic lymphocytic leukemia (CLL) in the era of novel agents
    Meeting Abstract

    Roeker, L. E.; Brown, J. R.; Dreger, P.; Lahoud, O. B.; Eyre, T. A.; Brander, D. M.; Skarbnik, A.; Coombs, C. C.; Kim, H. T.; Manchini, S. T.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis
    Meeting Abstract

    Sanchez, L.; Landau, H. J.; Rosenbaum, C. A.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A multicenter retrospective analysis of clinical outcomes, toxicities, and patterns of use in institutions utilizing commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B-cell lymphomas
    Meeting Abstract

    Riedell, P. A.; Walling, C.; Nastoupil, L. J.; Pennisi, M.; Maziarz, R. T.; McGuirk, J. P.; Oluwole, O. O.; Bachanova, V.; Hwang, W. T.; Schuster, S. J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Sparing of the lower gastrointestinal tract microbiota is associated with reduced acute graft-versus-host disease
    Meeting Abstract

    Ponce, D. M.; Burgos da Silva, M. D.; Gomes, A. L. C.; Moore, G.; Slingerland, J. B.; Pamer, E. G.; Taur, Y.; Peled, J. U.; van den Brink, M. R. M.
    Blood (2019)

    Fulltext@MSK | Save